Tissue World Magazine
Alexandra Stuthridge, Technical Business Manager, BioProducts Institute (BPI)

Essity has said it is closing a converting facility for retail branded products in Saint-Étienne-du-Rouvray and will invest in its remaining integrated production facilities in France.

The closure is to “further strengthen competitiveness and increase efficiency” and is expected during the fourth quarter of 2018.

It said the move was aligned with its strategy “to optimise the production footprint, to increase cost and capital efficiency, and further increase value creation in the consumer tissue business area”.

The restructuring costs are expected to be SEK 480m, of which approximately SEK 430m is expected to be recognized as an item affecting comparability in the third quarter of 2018.